Ophthlamology – Our Trials

Our Trials

rs154038_pg1_9383-hpr

SEQUIOA

Click here for more Information
More Information

If you think you would be suitable for the study please discuss with your doctor at your next clinic appointment.

DME

Click here for more Information

This is a randomised, double-masked, placebo controlled exploratory study to evaluate pharmacodynamics, safety and tolerability of orally administered BI 1026706 for 12 weeks in patients with mild visual impairment due to centre-involved diabetic macular edema (DME). It is estimated that approximately 100 patients with DME will participate worldwide in this trial in about 8 countries. Patients will be randomly assigned to receive either the investigational drug BI 1026706 or placebo. Each patients participation in the trial will last approximately 4.5 months and will require approximately 6 visits to the trial clinic.

If you think you would be suitable for the study please discuss with your doctor at your next clinic appointment.

GA Study

Click here for more Information

Geographic Atrophy (GA) is an advanced form of age-related macular degeneration (AMD), affecting over 5 million people worldwide, and in the UK is estimated to account for 26% of legal blindness. The incidence of GA increases exponentially with age and there is currently no treatment.
The disease impact on the patient, caregiver and society due to GA is not being well understood. The purpose of this observational study is to assess the clinical details and health-related quality of life of patients with GA compared to patients without GA.
This study also aims to describe the healthcare costs associated with GA and collect data from caregivers of patients with GA in order to understand the effect on the caregiver’s life due to caring for a patient with this condition.
Patients with and without GA meeting the study criteria for eligibility will be invited to participate in the study by the treating physician or research nurse. Information on the study will be provided to the patient.
If patients consent to participate, the physician or a member of the research team will collect data regarding their medical history and other relevant data onto an electronic case report form (eCRF). Patients will be invited to complete questionnaires providing information on patient-reported outcomes (PRO) at time of the visit. In addition, if the GA patient has a caregiver, the caregiver will be invited to complete questionnaires providing information on caregiver reported outcomes following informed consent.

If you think you would be suitable for the study please discuss with your doctor at your next clinic appointment.

©2017 Royal Surrey County Hospital

Feedback We would love to hear from you
Send

Log in with your credentials

or    

Forgot your details?